Clinical Trial 39540

Watertown, MA 02472


Study Summary:

Study 39357 Flyer

If you suffer from frequent migraines, consider participating in a clinical research study!

    The Breeze Study is a clinical trial testing the safety, tolerability and effectiveness of a natural investigational nasal spray in preventing migraines. If you are eligible, study-related care and medication will be provided at no cost to you.

    To be eligible you must:
    • Be between 18-65 years old
    • Have at least a 1-year history of migraine
    • Experience between 4-14 migraine days per month and 3-14 migraine attacks per month
    • Able and willing to complete a daily migraine-history diary using an electronic device
    (Additional study requirements will be discussed with a study representative.)

    Migraine is a chronic, recurrent disorder characterized by moderate to severe headache with throbbing pain that usually lasts from 4 to 72 hours that affects approximately 37 million Americans. Episodic migraine is characterized by up to 14 migraine days per month, while chronic migraine is 15 or more migraine days per month.

    Symptoms may include:
    • Pain on one side or both sides of your head
    • Throbbing or pulsing pain
    • Sensitivity to light and sound
    • Nausea and vomiting
    • Blurred vision
    • Lightheadedness
    If you are interested in participating in the Breeze Study, schedule a call to speak with a study representative regarding your eligibility and available study locations near you.


    Study is Available At:

    To learn more about this study and see if you qualify visit www.breezestudy.com.

    To view an updated list of participating research sites Click Here.

     


    Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.